Adrian Harel

Adrian Harel

Chief Executive Officer at MEDICORTEX FINLAND OYJ
69 year
Consumer Services
Health Technology
Consumer Non-Durables

Profile

Adrian Harel is currently Chief Executive Officer & Director at Medicortex Finland Oyj since 2014 and Chief Executive Officer & Director at Medicortex International AB starting in 2026.
Former roles include Chief Executive Officer at Meditor Pharmaceuticals Ltd. and Aminolab Technologies 2000 Ltd. from 2008 to 2010, Chief Executive Officer at ProNeuron Oy, Director-Research & Development at Brainstorm Cell Therapeutics, Inc. in 2013, and Chief Operating Officer at Sepal Pharma Ltd. and WBT Ltd. from 2003 to 2007.
Education includes a doctorate from the Weizmann Institute of Science, an MBA from the University of Haifa, and a doctorate from Washington University School of Medicine.

Adrian Harel active positions

CompaniesPositionStart
MEDICORTEX FINLAND OYJ Chief Executive Officer 01/06/2014
NOSIUM AB Chief Executive Officer 01/07/2026

Former positions of Adrian Harel

CompaniesPositionEnd
BRAINSTORM CELL THERAPEUTICS INC. Chief Executive Officer 24/12/2013
Meditor Pharmaceuticals Ltd.
President -
Aminolab Technologies 2000 Ltd.
President -
Sepal Pharma Ltd.
Chief Operating Officer 01/01/2007
WBT Ltd.
Chief Operating Officer 01/01/2007
See the detail of Adrian Harel's experience

Training of Adrian Harel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

14

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Consumer Services

Sepal Pharma Ltd.

Meditor Pharmaceuticals Ltd.

WBT Ltd.

Aminolab Technologies 2000 Ltd.

Consumer Services

Consumer Services

Consumer Non-Durables

Health Technology

Health Services

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!